Cover Image

Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model

Psychiatric comorbidities are prevalent in patients with epilepsy and greatly contribute to the overall burden of disease. The availability of reliable biomarkers to diagnose epilepsy-associated comorbidities would allow for effective treatment and improved disease management. Due to their non-invas...

Full description

Saved in:
Bibliographic Details
Main Authors: Di Liberto, Valentina (Author) , van Dijk, R. Maarten (Author) , Brendel, Matthias (Author) , Waldron, Ann-Marie (Author) , Möller, Christina (Author) , Koska, Ines (Author) , Seiffert, Isabel Leonie (Author) , Gualtieri, Fabio (Author) , Gildehaus, Franz-Josef (Author) , Ungern-Sternberg, Barbara von (Author) , Lindner, Magdalena Julia (Author) , Ziegler, Sibylle (Author) , Palme, Rupert (Author) , Hellweg, Rainer (Author) , Gass, Peter (Author) , Bartenstein, Peter (Author) , Potschka, Heidrun (Author)
Format: Article (Journal)
Language:English
Published: 20 June 2018
In: Neurobiology of disease
Year: 2018, Volume: 118, Pages: 9-21
ISSN:1095-953X
DOI:10.1016/j.nbd.2018.06.010
Online Access:lizenzpflichtig
lizenzpflichtig
Get full text
Author Notes:Valentina Di Liberto, R. Maarten van Dijk, Matthias Brendel, Ann-Marie Waldron, Christina Möller, Ines Koska, Isabel Seiffert, Fabio Gualtieri, Franz Josef Gildehaus, Barbara von Ungern-Sternberg, Magdalena Lindner, Sibylle Ziegler, Rupert Palme, Rainer Hellweg, Peter Gass, Peter Bartenstein, Heidrun Potschka
Description
Summary:Psychiatric comorbidities are prevalent in patients with epilepsy and greatly contribute to the overall burden of disease. The availability of reliable biomarkers to diagnose epilepsy-associated comorbidities would allow for effective treatment and improved disease management. Due to their non-invasive nature, molecular imaging techniques such as positron emission tomography (PET) are ideal tools to measure pathologic changes. In the current study we investigated the potential of [18F]fluoro-2-deoxy-d-glucose ([18F]FDG) and 2′-methoxyphenyl-(N-2′-pyridinyl)-p-18F-fluoro-benzamidoethylpiperazine ([18F]MPPF) as imaging correlates of neurobehavioral comorbidities in the pilocarpine rat model of epilepsy. Findings from rats with epilepsy revealed a regional reduction in [18F]FDG uptake indicating thalamic hypometabolism. In addition, an increase in septal [18F]MPPF binding was observed in rats with spontaneous recurrent seizures. Both thalamic [18F]FDG and septal [18F]MPPF data proved to correlate with behavioral alterations including decreases in luxury behavior such as burrowing and social interaction, and changes in behavioral patterns in anxiety tests. A correlation with seizure frequency was confirmed for thalamic [18F]FDG data. Moreover, thalamic [18F]FDG and septal [18F]MPPF data exhibited a correlation with brain-derived neurotrophic factor (BDNF) serum concentrations, which were lowered in rats with epilepsy. In conclusion, μPET data from rats with pilocarpine-induced epileptogenesis indicate altered septal 5-HT1A receptor binding. Further research is necessary assessing whether septal 5-HT1A receptor binding may serve as an imaging correlate of neuropsychiatric comorbidities in epilepsy patients and for severity assessment in rodent epilepsy models. In contrast, we obtained evidence that [18F]FDG uptake also reflects the severity of epilepsy and, thus, might not constitute a biomarker with sufficient specificity for psychiatric comorbidities. Evidence has been obtained that BDNF might serve as a peripheral circulatory biomarker. Further experimental and clinical assessment is necessary for validation of the marker candidates.
Item Description:Gesehen am 28.02.2020
Physical Description:Online Resource
ISSN:1095-953X
DOI:10.1016/j.nbd.2018.06.010

Similar Items